The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients
2 other identifiers
interventional
19
1 country
1
Brief Summary
The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Apr 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2007
CompletedJuly 9, 2009
July 1, 2009
1.8 years
September 13, 2005
July 8, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
increase in lean body mass
12 months
Secondary Outcomes (1)
increase in physical functioning
12 months
Study Arms (2)
1
ACTIVE COMPARATORonly protein supplementation
2
ACTIVE COMPARATORprotein supplementation plus exercise
Interventions
oral administration of 2 cans of protein supplement (lactose-free formula that contains a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat); every other day, 3 days per week, for 6 months
Eligibility Criteria
You may qualify if:
- On hemodialysis for more than 3 months, on a thrice weekly hemodialysis program;
- Adequately dialyzed (Kt/V ≥ 1.2).
- Age ≥ 18 years old.
You may not qualify if:
- Patients unable to perform exercise due to cardiovascular disease, osteoarthritis, etc., as determined by the PI and the primary physician of the subject.
- Pregnant women.
- Patients hospitalized within the last month prior to the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alp Ikizler, MD
Vanderbilt University Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 15, 2005
Study Start
April 1, 2005
Primary Completion
January 1, 2007
Study Completion
January 1, 2007
Last Updated
July 9, 2009
Record last verified: 2009-07